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Fgf8transcription factor Tp63 is expressed in the basal cells of multiple epithelial
tissues. In humans, mutations in TP63 have been identiﬁed in ﬁve distinct human developmental disorders
that are characterized by limb abnormalities, ectodermal dysplasia, and facial anomalies. To dissect the
molecular pathogenesis of the bilateral cleft lip and cleft palate that results from mutation of Tp63, we
analysed Tp63 mutant mice. At E10.5, Tp63-deﬁcient mice exhibited abnormal morphogenesis of the medial
nasal, lateral nasal and maxillary processes. Analysis of key signaling molecules revealed that these defects
result from increased Bmp4 signaling in the epithelia of the facial processes. Acting antagonistically on Fgf8
and Shh, this aberrant signaling led to a reduction in mesenchymal cell proliferation and increased cell death
in speciﬁc regions of the facial processes. In addition, a proliferative defect in the mesenchyme of the
maxillary processes at E11.5 resulted in absence of the anterior region of the palatal shelves and,
subsequently, cleft palate. Our results are consistent with a role for Tp63 in the regulation of Bmp signaling
controlling the growth, modelling and fusion events underlying facial development and shed new light on
the complex abnormality of facial clefting.
© 2008 Elsevier Inc. All rights reserved.Introduction
Orofacial clefting (OFC), encompassing clefts of the lip and palate,
is a common congenital disorder which occurs with an incidence that
has been estimated at 1 in 500–2500 live births (Murray, 2002). OFC
may present as part of a syndromewhere structures other than the lip
and palate are affected, or as an isolated entity. Attempts to dissect the
genetic basis of non-syndromic OFC have proven problematical as
both genetic and environmental factors are known to play a role in its
pathogenesis; it has been estimated that as many as 14 interacting loci
may be involved in non-syndromic clefting (Schliekelman and Slatkin,
2002). Recent successes in delineating the molecular mechanisms
underlying OFC have been driven largely by the analysis of human
clefting syndromes. In this regard, mutations in the transcription
factor TP63 have been found to underlie ﬁve distinct autosomal
dominant developmental disorders in man, a subset of which exhibit
cleft lip and palate as a deﬁning feature; these disorders include
ectrodactyly, ectodermal dysplasia, clefting (EEC) syndrome (MIM
604292) and ankyloblepharon, ectodermal dysplasia, clefting (AEC)
syndrome (MIM 106260) (Celli et al., 1999, McGrath et al., 2001).
The TP63 gene is a member of the p53 family which encodes at
least six protein variants owing to two different transcription start).
l rights reserved.sites and alternative splicing. Three isoforms contain N-terminal
transcriptional activation (TA) sequences, while the other three (ΔN)
isoforms do not. In addition, alternative splicing towards the carboxy
terminus generates three subtypes; α, which encodes a sterile alpha
motif (SAM) domain and a transactivation inhibitory domain (TID),
and β and γ, from which the SAM and TID domains are absent (van
Bokhoven and Brunner, 2002). The different protein isoforms all
display DNA-binding and tetramerisation domains but vary in their
ability to transactivate both p53-responsive genes and other Tp63
isoforms, and in their ability to mediate cell cycle arrest and apoptosis
(Yang et al., 1998; Ghioni et al., 2002). The predominant isoform
expressed during embryogenesis is thought to be ΔN-Tp63α, which is
found in the basal layer of many epithelial tissues (Yang et al., 1999;
Laurikkala et al., 2006). Mice lacking all Tp63 isoforms die at birth and
exhibit severe developmental defects including limb truncations,
epidermal defects and craniofacial anomalies (Mills et al., 1999; Yang
et al., 1999). The epidermis is thin, fails to stratify and lacks ectodermal
appendages such as hairs, whiskers, teeth and several glands
including mammary, salivary and lacrimal glands (Mills et al., 1999;
Yang et al., 1999). The epidermal phenotype has been interpreted to
result from lack of proliferative potential of the Tp63-deﬁcient
epidermal stem cells (Yang et al., 1999) or lack of commitment of
the immature ectoderm to epidermal lineages (Mills et al., 1999).
Despite considerable research into the epidermal (Koster, Huntzinger
and Roop, 2002; Keyes et al., 2006) and dental anomalies in Tp63
274 H.A. Thomason et al. / Developmental Biology 321 (2008) 273–282knockout mice (Laurikkala et al., 2006), the nature of the craniofacial
anomalies and their underlying developmental pathogenesis has not
been characterised.
Development of the craniofacial complex involves a complex series
of events that requires the close co-ordination of programs for cell
migration, growth, differentiation, and apoptosis. Neural crest cells,
which delaminate from the neural folds, contribute to and migrate
through themesenchymal tissue into the craniofacial regionwhere, by
the fourthweek of embryonic development inman, they participate in
the formation of the frontonasal prominence, the paired maxillary
processes, and the paired mandibular processes surrounding the
primitive oral cavity. The formation of the nasal placodes by the end of
the fourth week of embryogenesis divides the lower portion of the
frontonasal prominence into paired medial and lateral nasal pro-
cesses. Towards the end of the sixth week of development, merging of
the medial nasal processes with one another and with the maxillary
processes on each side leads to the formation of the upper lip and the
primary palate.
The ﬁrst sign of overt development of the secondary palate occurs
during the sixth week of embryogenesis with outgrowth of paired
palatal shelves from the maxillary processes. The palatal shelves
initially grow vertically down the sides of the tongue but, during the
seventh week of development, they elevate to a horizontal position
above the tongue, contact and fuse to form a midline epithelial seam
which subsequently degenerates to allow mesenchymal continuity
across the palate. These fusion processes are complete by the tenth
week of embryogenesis. The development of the mammalian
secondary palate thereby divides the oronasal space into separate
oral and nasal cavities.
To dissect the role of Tp63 during craniofacial development, and to
determine why mutation of TP63 contributes to orofacial clefting in
humans, we analysed the expression of Tp63 and characterised the
craniofacial defects in Tp63-null mice. We demonstrate that loss of
Tp63 resulted in increased Bmp signaling in several areas of the facial
processes. Consequently down-regulation of the key signaling
molecules Fgf8 and Shh led to reduced mesenchymal cell prolifera-
tion, regional growth defects and altered morphogenesis of the nasal
processes resulting in a bilateral cleft of the upper lip. We also
demonstrate that a proliferative defect in the mesenchyme of the
maxillary processes at embryonic day 11.5 leads to absence of the
entire anterior region of the secondary palate during the initial stage
of palatogenesis. Our results provide molecular evidence that Tp63-
mediated, epithelial-derived signals are crucial during the outgrowth
and modeling of the facial processes and in the initial stages of palatal
growth.
Materials and methods
Tissue preparation, scanning electron microscopy,
immunohistochemistry and in situ hybridisation
The generation and genotyping of the Tp63−/− mice have been
described previously (Yang et al., 1999). Mice were housed in
accredited animal facilities at the University of Manchester. All
procedures were approved by local Ethical Review Committees and
are licensed under the Animal (Scientiﬁc Procedures) Act 1986, issued
by the Home Ofﬁce, Her Majesty's Government, London, United
Kingdom. BALB/c-derived Tp63−/− embryos were obtained by hetero-
zygous matings, the morning of the vaginal plug being considered
E0.5. Tissues were ﬁxed in either 4% paraformaldehyde or Bouin's
reagent and processed for histological examination, scanning electron
microscopy or immunohistochemistry using standard protocols
(Dixon et al., 2000; Knight et al., 2006). Antibodies were obtained
from Santa Cruz (SC-8344, SC-8608; California, USA) and R and D
systems (activated caspase 3, AF835; Minneapolis, USA). The whole-
mount and section in situ hybridization protocols have been describedpreviously (Knight et al., 2006, Wilkinson et al., 1987). During all
assays, wild-type and Tp63-null embryos were treated identically. In
particular, during whole-mount in situ hybridization assays to
compare gene expression levels, embryos of both genotypes were
incubated in the detection reagent for identical periods of time.
Organ culture and cell proliferation assays
E13.5 palatal shelves were dissected from Tp63 null mice and wild-
type littermates in sterile Dulbecco's MEN/NUT Mix F-12 (Ham)
containing 0.05 mM L-glutamate, 0.25 mM glycine and 15 mM Hepes
with 1% penicillin–streptomycin and freshly added L-ascorbic sodium
salt at 40 µg/ml ﬁnal concentration and cultured as described
previously (Ferguson et al., 1984). Cell proliferation assays were
performed as described previously (Richardson et al., 2006). Three
non-serial sections were counted from three Tp63−/− and three wild-
type embryos, from one or more litters. All assays were analysed by
two individuals and the mean value recorded. Mann–Whitney U
statistical tests were performed using SPSS 13.0.
Results
ΔNp63α is widely expressed during facial development
To characterise the expression domains of Tp63 during facial
development, we performedwhole-mount in situ hybridization assays
on E9.5–E12.5 mouse embryos. These studies indicated that Tp63
transcripts were widely expressed during facial development and
appeared at particularly high levels in the epithelia of the maxillary
and mandibular components of the ﬁrst branchial arch at E9.5, the
lateral and medial nasal processes as they fused at E10.5, the leading
edges of the upper lip and mandible at E11.75 and the nasolacrimal
groove at E12.5 (Fig. 1, A–D). Immunostaining using a panel of
antibodies directed against all protein isoforms of Tp63 (pan-Tp63;
4A4), ΔN-Tp63 and Tp63α isoforms were identical, conﬁrming
previous observations that the main embryonic isoform is ΔN-
Tp63α (Yang et al., 1999, Laurikkala et al., 2006). Similar experiments
using a TA-Tp63-speciﬁc antibody failed to detect these isoforms at
any of the embryonic stages examined. These observations were
conﬁrmed by RT-PCR and real-time PCR (data not shown). We
observed strong staining for ΔN-Tp63α in all basal cells of the
ectoderm of the facial processes from E9.5 (data not shown). Initially,
we detected intense Tp63 staining in basal cells of the ectoderm in the
most distal regions of the medial and lateral nasal processes at E10.5
(Fig. 1E). Subsequently, this expression domain was conﬁned to only
the ectodermal component of the nasal processes at E11.5 (Fig. 1G).
Staining was present in all basal cells of the ectoderm covering the
maxillary processes during E10–E12 (Fig. 1, F,H) and at all stages of
development of the secondary palate from E11.5 to E14.5 (Fig. 1, I–L)
and at E15.5 (data not shown).
Tp63−/− embryos display bilateral cleft lip and cleft palate
Tp63−/− embryos exhibited a fully penetrant bilateral cleft lip and a
complete cleft of the secondary palate (n=137) (Fig. 2, A–D). This
phenotype was ﬁrst apparent at E11.5, when the maxillary processes
were observed to be smaller in Tp63−/− mice than in Tp63+/− or Tp63+/+
littermates (Fig. 2, E, F). In addition, the medial nasal processes had a
more rounded appearance and failed to meet the lateral nasal
processes in the most distal regions (Fig. 2F). Histological analysis of
a developmental series of Tp63−/− embryos determined that the facial
processes were abnormally shaped and the lateral nasal processes and
maxillary processes appeared smaller than those of their wild-type
littermates (Fig. 2, G–J). The medial and lateral nasal processes
remained apart in all Tp63−/− embryos examined, although serial
sections through Tp63-null embryos revealed that the posterior
Fig. 1. Expression of Tp63 during facial morphogenesis. (A–D) Whole-mount in situ hybridization. (A) At E9.5, Tp63 is expressed throughout the ectoderm of the facial processes and
the maxillary and mandibular components of the ﬁrst branchial arch. (B) At E10.5, Tp63 is detected in the ectoderm surrounding the nasal pit and in the maxillary processes. (C) At
E11.75, Tp63 transcripts are identiﬁed in the leading edges of the mandible and the fused regions of the medial nasal processes. (D) Tp63 is expressed intensely in the nasolacrimal
groove at E12.5 (arrowed). (E–L) Immunohistochemistry using the p63 antibody 4A4 on coronal sections of wild-type embryos. (E and F) At E10.5, Tp63 expression is detected in basal
cells of the ectoderm in the most distal portions of the medial and lateral nasal processes (E) and throughout the ectoderm of the mandibular and maxillary process (F). (G and H) At
E11.5, Tp63 expression is conﬁned to the ectodermal component of the nasal pit (G) and is expressed highly in the fusion region between the medial nasal process and maxillary
process (arrowed) (H). (I–L) During development of the secondary palate, Tp63 staining is detected in the ectoderm throughout the oral cavity from E11.5 (I), the developing tooth
germs from E12.5 (J), and in the palatal shelves from E12.5 to E14.5 (J–L). fnp, frontonasal process; mnd, mandible; mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal
process; p, palate; t, tongue; tg, tooth germ. Scale bars: E–K; 200 µm; L, 100 µm.
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the maxillary processes via an “epithelial bridge” (Fig. 2J). In addition,
the defects of the secondary palate were particularly severe in the
anterior region, which was completely absent in Tp63−/− embryos at
E12.5 and markedly smaller at E13.5 (Fig. 2, K–N). Skeletal analysis of
E18.5 Tp63−/− embryos revealed abnormalities of the nasal capsule,
absence of the premaxilla and palatal processes of the maxilla and
palatine bone (Fig. 2, O, P). Although the overall morphology of the
Tp63−/− mice suggested that the defect in palatogenesis occurred as a
result of abnormal growth and patterning during early embryogen-
esis, we conﬁrmed that the palatal shelves were competent to fuse
with one another using in vitro organ culture (Ferguson et al., 1984).
Palates from E13.5 wild-type and Tp63−/− mice were dissected, placed
in close proximity and cultured for 24 or 48 h. Histological analysis
conﬁrmed that after 24 h all Tp63−/− explants had fused in the midline
and, in most cases, the epithelial seam had started to degenerate (Fig.
2, Q, R). After 48 h of culture, all Tp63−/− explants were fully fused with
no evidence of a midline epithelial seam (data not shown). These data
indicate that the palates of Tp63−/− mice are capable of fusion and that
the cleft palate occurs as a result of failure of growth of the individual
palatal shelves.
Tp63-mediated signaling is essential for cell survival
Scanning electron microscopy revealed that the facial processes of
wild-type mice were covered by ﬂattened, regular periderm cells,
whereas the tips of the lateral nasal processes and the maxillary
processes of Tp63−/− embryos were decorated with rounded irregular
cells that appeared to be sloughing away from the underlying
epithelium (Fig. 3, A–D). These cells were not periderm in nature;
indeed, Tp63-null mice do not form a periderm layer as judged bykeratin 17 immunoﬂuorescence assays (data not shown). These
abnormal cells were evident in histological sections (Fig. 3, E–H) and
stained positively for activated caspase-3, conﬁrming that the cells
were undergoing inappropriate cell death (Fig. 3, I, J). We were unable
to ﬁnd any areas of cell death within the mesenchyme of the facial
processes or secondary palate in Tp63−/− embryos (Fig. 3, I, J and data
not shown). In light of these observations, we hypothesized that while
the epithelial cell death might be a contributory factor to the cleft lip,
it could not account for the smaller maxilla observed in Tp63−/−
embryos. We therefore analysed neural crest cell migration by
examining the expression patterns of the neural crest marker Sox10
(Southard-Smith et al., 1998). These experiments determined that
Sox10 expression patterns were comparable in the Tp63−/− embryos
and their wild-type littermates, indicating that the migration of
neural crest cells into the developing branchial arches was unaffected
in Tp63−/− mice (Fig. S1).
Tp63−/− embryos display mesenchymal proliferation defects
To further investigate the pathogenesis of the cleft lip and palate in
the Tp63−/−mice, we analysed cell proliferation in E10.5–E12.5 mutant
embryos and their wild-type littermates using BrdU incorporation
assays. We hypothesised that for the facial processes to form the
correct shape to allow contact and fusion, there were likely to be
different proliferation rates in different regions of the facial processes.
Thus, the medial nasal, lateral nasal and maxillary processes were
divided into sub-regions which were analysed individually. It proved
impossible to assess proliferation within the epithelia of the facial
processes as it appeared unhealthy and, in many areas, was detached
from the mesenchyme (Fig. 2L). These assays determined that the
mesenchyme within the facial processes of E10.5 wild-type embryos
Fig. 2. Phenotype of Tp63−/− mice. (A–D) Tp63−/− mice exhibit a fully penetrant bilateral cleft lip (B) and complete cleft of the secondary palate (D). (E and F) The phenotype is ﬁrst
apparent at E11.5, when, in comparison towild-type littermates, themaxillary processes of Tp63−/− embryos appear smaller and themedial nasal processes appear rounded at the tips
and bulge medially (F). (G–J) Coronal sections of E11.5 embryos reveal small, unusually shaped facial processes in Tp63−/− embryos. An epithelial bridge between the medial nasal
processes and the maxillary processes is evident (arrowed in panel J). (K–N) Development of the anterior secondary palate. Coronal sections indicate that, in comparison to wild-type
littermates, palatal outgrowth in Tp63−/− embryos is absent at E12.5 (L) and rudimentary at E13.5 (N). (O and P) Ventral views of the craniofacial skeleton of E18.5 Tp63−/− embryos
reveal abnormalities of the nasal capsule, absence of the premaxilla and palatal processes of the maxilla and palatine bone (asterisk in panel P). (Q and R) In vitro palate culture.
Histological analysis of palates dissected from E13.5 wild-type and Tp63−/− embryos after culture for 24 h indicated that Tp63−/− explants fused in the midline with no evidence of an
epithelial seam (arrowed in the wild-type palate, Q). mnd, mandible; mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal process; p, palate; t, tongue; ns, nasal
septum; pmx, pre-maxilla. Scale bars: A and B, 1 mm; C–F, 500 µm; G–L, 300 µm; M and N, 200 µm.
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from 42% to 58%. Although there was no signiﬁcant difference in
proliferation within any region of the facial processes of Tp63−/− mice
compared to control littermates at this age, the lateral nasal processes
and the maxillary processes had signiﬁcantly lower total cell counts
than those of the wild-type littermates (P values=0.05; Fig. S2). The
total cell count in these processes was also signiﬁcantly lower at E11.5
(P=0.05; Fig. 4). When proliferation rates were assessed at E11.5, three
regions of the facial processes in Tp63−/− embryos were found to
contain signiﬁcantly fewer BrdU-labelled cells; region 4 of the lateral
nasal process (P=0.014), region 2 of the medial nasal processes
(P=0.014), and region 4 of the maxillary processes (P=0.027, Fig. 4, L–
N). Intriguingly, region 4 of the maxillary process is the medial aspect
fromwhich the palatal shelves emerge late on E11. These data led us to
extend our studies to the next stage of palate development. Aftercomparisons of the morphology of the wild-type and Tp63−/− embryos
at E12.5, we were unable to ﬁnd any evidence of palatal shelf
outgrowth from the anterior maxillary processes of Tp63−/− embryos.
We therefore divided the mid and posterior palate into medial and
lateral regions. At E12.5, we demonstrated that the posterior palate
contained signiﬁcantly fewer cells, predominantly due to a signiﬁ-
cantly lower total cell count in the medial aspect (P=0.05, Fig. S3, G),
although both the medial and lateral aspects of the posterior palate
were signiﬁcantly more proliferative (P=0.05, Fig. S3, H).
Altered signaling in the facial processes of p63−/− embryos
To analyse the molecular events underlying the facial clefting
observed in Tp63−/− mice, we performed whole-mount in situ
hybridization on E10.5 to E12.5 mouse embryos, focussing on key
Fig. 3. Cell death in Tp63−/− embryos. (A–D) Scanning electron microscopy of the facial
processes at E11.5. (A and C) The epithelia of wild-type embryos appear smooth and are
covered in ﬂattened periderm cells with distinct cell–cell junctions and central nuclei.
(B) In contrast, the lateral nasal processes and maxillary processes of Tp63−/− embryos
exhibit an area of rounded cells covered in ﬁlamentous debris. (D) At higher
magniﬁcation, the cells appear to be sloughing away from the underlying epithelium.
(E–H) Histological analysis of coronal sections indicates that the epithelium covering the
maxillary processes of E11.5 Tp63−/− embryos appears irregular with dark, condensed
nuclei (arrowed in panel H). (Panels G and H are higher magniﬁcations views of the
boxed regions in panels E and F). (I and J) Anti-activated caspase 3 immunohistochem-
istry. (I) No apoptotic cells are detected in the wild-type embryo, whereas numerous
cells in the Tp63−/− embryos exhibit immunoreactivity (arrowed) conﬁrming that the
cells are undergoing inappropriate cell death (J). mnd, mandible; mx, maxillary process;
mnp, medial nasal process; lnp, lateral nasal process; n, nuclei. Scale bars: A and B,
200 µm; C and D, 20 µm; E and F, 200 µm; G and H, 50 µm; I and J, 100 µm.
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esis, including members of the Bmp, Shh and Fgf families (Wilkie and
Morriss-Kay, 2001; Richman and Lee, 2003). At E10.5 and E11.5 the
secreted signaling molecule Bmp4 is expressed at low levels in the
epithelia covering the medial and lateral nasal processes and
maxillary and mandibular processes in wild-type embryos (Francis-
West et al., 1994). In contrast, in Tp63−/− embryos, Bmp4 transcripts
appeared markedly elevated in the epithelium of the caudal region of
the lateral nasal processes at E10.5 and in the anterior region of the
maxillary processes at E10.5 and E11.5 (Fig. 5, A–D). Alterations in Bmp
signaling have previously been shown to affect the expression of Fgf8(Barlow et al., 1999; Shigetani et al., 2000), which is expressed in both
complementary and overlapping domains with Bmp4 (Crossley and
Martin, 1995). At E10.5 and E11.5, Fgf8 expression was detected in the
epithelia of the medial and lateral nasal processes and the maxillary
and mandibular processes of wild-type embryos. In Tp63−/− embryos,
however, we observed marked changes in Fgf8 expression. At E10.5,
Fgf8 transcripts were absent from the epithelia covering the distal
tips of the medial nasal processes, the entire lateral nasal processes
and the anterior region of the maxillary processes (Fig. 5, E, F). At
E11.5, Fgf8 expression was absent from the epithelia of the anterior
maxillary processes and was down-regulated in the rostral region of
the lateral nasal processes (Fig. 5, G, H). All of these epithelial regions
overlie areas of the mesenchyme inwhich we identiﬁed a proliferative
defect (Fig. 4, L–N). To investigate the downstream consequences of
the loss of Fgf8 expression, we examined the expression of the Fgf8
target gene, Barx1 (Barlow et al., 1999). These assays determined that
the medially located expression domains of Barx1were reduced in the
mesenchyme of the Tp63−/− maxillary processes, although a more
lateral expression domainwas still present in posterior regions (Fig. 5,
I, J). Subsequently, we examined the expression pattern of Shh, which
is expressed in the ectoderm of the facial primordia (Echelard et al.,
1993; Hu and Helms, 1999) and has been shown to interact with BMP
andMsx1 in regulating mammalian palatogenesis (Zhang et al., 2002).
In Tp63−/− embryos, we found that expression of Shh was down-
regulated in the medial nasal processes and roof of the oral cavity, and
was absent from the entire maxillary process (Fig. 5, K, L).
As the major site of altered gene expression appeared to be the
anterior region of the maxillary processes, we performed section
in situ hybridization to identify the precise regions affected in
Tp63−/− embryos. These studies conﬁrmed that Bmp4 was present
at much higher levels in the epithelia of Tp63−/− embryos,
particularly in the medial region of the anterior maxillary
processes (Fig. 6, A, B), corresponding to region 4, in which we
identiﬁed a proliferative defect in the mesenchyme (Fig. 4, N).
Conversely, Fgf8 expression was lost from this region (Fig. 6, E, F).
In the posterior region of the maxillary processes, Bmp4 was not
expressed in wild-type embryos nor Tp63−/− embryos (Fig. 6, C, D).
Fgf8 expression in the posterior region of the maxillary processes
of Tp63−/− embryos was comparable to that observed in wild-type
littermates (Fig. 6, G, H). Expression of Barx1 appeared to be
reduced in the mesenchyme of the anterior region of the maxillary
processes of Tp63−/− embryos, but was unaffected in the posterior
region (Fig. 6, I–L).
Expression of Msx1, which is localised in the nasal processes and
anterior maxillary process in wild-type embryos, appeared slightly
up-regulated in the maxillary and medial nasal processes of Tp63−/−
embryos (Fig. S4 A, B). Expression domains of additional markers,
including the Fgf8 target genes Pyst1 (Kawakami et al., 2003), Pea3,
Erm and Pax3 (Firnberg and Neubuser, 2002) which are expressed in
the nasal processes, as well as Alx4, Dlx5 and Pax9, were unaltered in
Tp63−/− embryos in comparison to wild-type controls (Fig. S4 and data
not shown). Examination of markers expressed during later stages of
palatal development including Satb2, Osr2, Pax9 and Shox2 (FitzPatrick
et al., 2003; Lan et al., 2004; Yu et al., 2005) indicated that, although
the anterior region of the Tp63−/− palate at E12.5 and E13.5 exhibited
abnormal growth, the anterior to posterior patterning of the palatal
shelves was unaffected; for example Shox2, which is expressed
strongly in the mesenchyme of the anterior palate in wild-type
embryos, was expressed in the Tp63−/− rudimentary palatal shelves at
E13.5 (Fig. S4, O, P). These data conﬁrm that the altered signaling
events during outgrowth of the facial processes at E10.5 and E11.5
result in the absence of the entire anterior region of the secondary
palate during the initial stage of palatogenesis. At E13.5, although the
palatal shelves exhibit rudimentary growth, this is insufﬁcient for the
palatal shelves to make contact and fuse, ultimately resulting in a cleft
of the secondary palate. Nevertheless, the intrinsic molecular
Fig. 4. Cell proliferation in the facial processes of Tp63−/− embryos at E11.5. (A–J) Immunohistochemistry of coronal sections using an anti-BrdU antibody. The regions of the medial
nasal, lateral nasal and maxillary processes were deﬁned by the dashed lines as illustrated in panels A–D, and divided into regions as illustrated in panels panels E–J. (K) Total
mesenchymal cell counts of the entire facial processes. When compared to wild-type littermates (blue columns), Tp63−/− embryos (yellow columns) have signiﬁcantly fewer cells in
the lateral nasal processes and maxillary processes. Proliferation assays indicate that three regions of the facial processes of Tp63−/− embryos have signiﬁcantly fewer BrdU-labelled
cells; region 4 of the lateral nasal process (P=0.014) (L), region 2 of the medial nasal process (P=0.014) (M), and region 4 of the maxillary process (P=0.027) (N). These regionally-
speciﬁc differences are masked when the processes are analysed as a whole. Error bars are illustrated; an asterisk denotes a signiﬁcant ﬁnding using a Mann–Whitney U statistical
test. mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal process. Scale bars: A and B, 300 µm; C and D, 200 µm; E–J, 100 µm.
278 H.A. Thomason et al. / Developmental Biology 321 (2008) 273–282mechanisms which underlie anterior-posterior patterning are unaf-
fected in Tp63−/− embryos.
Discussion
Tp63−/− mice exhibit abnormal facial morphogenesis
In humans, mutations in TP63 have been identiﬁed in ﬁve distinct
developmental disorders including EEC and AEC syndromes, which
are characterised by varying degrees of limb abnormalities, ectoder-
mal dysplasias and facial clefting. To dissect the molecular pathogen-
esis of the facial anomalies resulting from mutation of Tp63, we have
analysed Tp63mutant mice. Loss of all Tp63 isoforms in mice results in
severe developmental defects including limb truncations, epidermaldefects and facial anomalies (Mills et al., 1999; Yang et al., 1999).
However, with the exception of the epidermal (Koster, Huntzinger and
Roop, 2002; Keyes et al., 2006) and dental anomalies (Laurikkala et al.,
2006), the phenotype of the Tp63-null mice has not been analysed in
detail. In this study, we have characterised the fully penetrant bilateral
cleft lip and cleft palate observed in Tp63−/− embryos and have
determined the underlying mechanisms. Development of the upper
lip involves a series of highly co-ordinated, genetically controlled,
morphogenetic events, including outgrowth and expansion of the
facial processes, programmed cell death, and fusion and subsequent
breakdown of the epithelial seam. Perturbation of any of these tightly
controlled steps may result in cleft lip. Central to all of these steps is
the establishment of correct facial morphogenesis; indeed, embryos
derived from the A/J and CL/Fr strains of mice, which have a high
Fig. 5. Altered signalling in the facial processes of Tp63−/− embryos detected bywhole-mount in situ hybridization. All images are ventral views except E and F, which are lateral views.
(A–D) Bmp4 transcripts are up-regulated in the caudal region of the lateral nasal processes of Tp63−/− embryos at E10.5 (B, red arrow) and in the anterior region of the maxillary
processes at E10.5 and E11.5 (black arrows) (B and D). (E and F) At E10.5, Fgf8 transcripts are absent from the lateral nasal processes, the tips of the medial nasal processes (arrowed)
and the anterior region of themaxillary processes (asterisk). (G and H) At E11.5, while expression of Fgf8 is clearly visible in the posterior region of themaxillary processes, expression
in the anterior region remains down-regulated. In addition, the lateral nasal processes exhibit patchy expression of Fgf8 in the epithelium surrounding the nasal pits (asterisk in panel
H). (I and J) The medially located expression domain of the Fgf8-target gene Barx1 is down-regulated in the anterior region of the maxillary processes of Tp63−/− embryos (arrowed),
although transcripts are present posteriorly. (K and L) Shh transcripts are absent from the anterior region of the maxillary processes of E11.5 Tp63−/− embryos (arrowed). mnd,
mandible; mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal process.
279H.A. Thomason et al. / Developmental Biology 321 (2008) 273–282frequency of spontaneous cleft lip, have more prominent andmedially
convergent medial nasal processes (Millicovsky et al., 1982; Trasler
and Ohannessian, 1983). We observed that the medial nasal processes
of Tp63−/− embryos at E11.5 were extremely rounded at their leading
edges, and were distinctly more prominent. Total cell counts revealed
that the lateral nasal processes and the developing maxillary
processes of Tp63−/− embryos were signiﬁcantly smaller than those
of the wild-type littermates at E10.5 and E11.5. We excluded the
possibility that these defects arise from altered neural crest cell
migration or from increased cell death in themesenchyme of the facial
processes and identiﬁed three areas of signiﬁcantly reducedmesench-
ymal cell proliferation at E11.5. As Tp63 is expressed in the basal cells
of the epithelia covering the facial processes, these data indicate that
the loss of Tp63 signiﬁcantly disrupts epithelial signaling during
outgrowth of the facial processes, resulting in two distinct but related
facial defects, cleft lip and cleft secondary palate.The origin of the cleft lip in Tp63−/− mice
During the critical stages of outgrowth of the facial processes in
Tp63−/− embryos we observedmarked changes in the expression levels
of key signaling molecules, including Bmp4 and Fgf8. The BMPs are a
group of secreted signaling molecules of the TGFβ superfamily which
regulate diverse developmental processes including cell proliferation,
apoptosis, differentiation and tissue morphogenesis (Wozney, 1998).
Regulation of BMP signaling is complex; for example, BMPs frequently
stimulate transcription of their own antagonists (Merino et al., 1998;
Stottmann et al., 2001; Laurikkala et al., 2003). In the chick, Ashique
and co-workers observed that BMP signaling is required to stimulate
proliferation and outgrowth of branchial arch mesenchyme, but also
observed that the chick globular process and anterior maxillary
prominence respond to increased BMP levels by programmed cell
death (Ashique et al., 2002). This is particularly intriguing as we found
Fig. 6. Altered gene expression in the anterior maxillary process of Tp63−/− embryos. (A–D) At E11.5, section in situ hybridization on coronal sections indicates that Bmp4 transcripts
are up-regulated in the anterior region of the maxillary processes, speciﬁcally in the medial region from which the palatal shelves originate (arrowed in panel B). (C and D) Bmp4
transcripts are not present in the posterior region of the maxillary processes of wild-type or Tp63−/− embryos. (E–H) Fgf8 transcripts are detected in the anterior region of the
maxillary processes of wild-type embryos, speciﬁcally in the medial region (E), but are absent from this region in Tp63−/− embryos (arrowed in panel F). (G and H) Fgf8 expression
appears to be unaltered in the posterior region of Tp63−/− embryos. (I–L) Expression of the Fgf8 target gene Barx1 is reduced in the anterior region of themaxillary processes of Tp63−/−
embryos (J) but unaltered posteriorly (L). mnd, mandible; mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal process. Scale bars: 200 µm.
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region of the lateral nasal processes and most rostral region of the
maxillary processes in Tp63−/− embryos at E11.5. These areas of cell
death correlated precisely with regions of increased Bmp4 expression
(compare Fig. 3, D and Fig. 5, D). During development of the upper lip
apoptosis is tightly regulated, with dying cells only being observed in
the epithelia of the fusing medial and lateral nasal processes and
maxillary processes at E11.5 (Jiang et al., 2006). This tight regulation
ensures that apoptosis does not occur before the facial processes have
made contact. Examination of chick facial primordia using scanning
electron microscopy has indicated that the lateral nasal processes
exhibit a region of apoptosis on the medial surface that likely
correlates with elevated BMP4 expression (Cox, 2004). As several
studies have linked BMP signalingwith cell death (Barlow and Francis-
West, 1997; Graham et al., 1994; Zhou and Niswander, 1996), we
conclude that the increased cell death observed in Tp63−/−mutants is a
direct consequence of elevated Bmp signaling (Fig. 5, A–D). We also
observed loss of Fgf8 signaling in the epithelia of the nasal and
maxillary processes and identiﬁed proliferative defects in the
mesenchyme underlying these regions in Tp63-null embryos. This is
extremely signiﬁcant as Fgf8 expression within the facial processes
has been correlated with high levels of cell proliferation and
expansion of the frontonasal mass mesenchyme (McGonnell et al.,
1998; Bachler and Neubüser, 2001). In addition, ectopic application of
Fgf8 has been shown to be capable of substituting for the facial
ectoderm in order to stimulate proliferation, promote cell survival and
regulate gene expression in the facial mesenchyme (Firnberg and
Neubuser, 2002). Conversely, stripping of the epithelium decreases
proliferation (Hu and Helms, 1999, Schneider et al., 2001). Our results
therefore provide evidence that the cleft lip observed in Tp63−/− miceresults from a combination of inappropriate cell death in the lateral
nasal process and maxillary processes, together with reduced
proliferation in the medial and lateral nasal processes and maxillary
processes. Interestingly, there are few genetic models of cleft lip with
or without cleft palate; those that have been reported exhibit a wide
variety in the penetrance of clefting (Juriloff and Harris, 2008). The
fully penetrant cleft lip phenotype characterised here is reminiscent of
that observed in mice with conditional ablation of Bmpr1a signaling
(Liu et al., 2005). Nestin cre;Bmpr1amice displayed elevated apoptosis,
not only in the epithelium of the medial nasal process, but also
extending into the underlyingmesenchyme (Liu et al., 2005). Whether
the cleft lip arises from increased Bmp signaling, as we have identiﬁed
in our study, or loss of Bmp signaling, it is clear that the emerging
network linking Tp63 and BMP signaling, which has also been
documented in other model organisms (Bakkers et al, 2002) and
developmental systems (Laurikkala et al., 2006) is essential in the
regulation of proliferation and apoptosis in the developing facial
processes.
The altered signaling events in the maxillary process underlie the cleft
secondary palate in Tp63−/− mice
Our section in situ hybridization data allowed us to demonstrate
that the altered signaling events in the developing facial processes
also had a deleterious affect upon the secondary palate. At E11.5,
Bmp4, which is expressed in the anterior palate only (Zhang et al.,
2002), was markedly up-regulated in the epithelia of the maxillary
processes of Tp63−/− embryos. Fgf8 expression, by comparison, was
lost from this region in Tp63−/− embryos. We also observed a
signiﬁcant mesenchymal proliferative defect in the anterior medial
281H.A. Thomason et al. / Developmental Biology 321 (2008) 273–282region of the developing maxillary processes, which subsequently
affected the initial stages of palatogenesis. In the posterior region of
the maxillary processes where Bmp4 is not expressed, Fgf8 signaling
and, consequently, growth and patterning in the posterior region of
the palate in Tp63−/− embryos appeared to be unaffected. While
expression of Fgf8 has not been reported for any of the later stages of
palatal growth, we postulate that expression of Fgf8 in the maxillary
processes at E11.5 acts to initiate palatal shelf outgrowth. This signal is
deﬁcient in Tp63-null mice, leading to a lack of the anterior palate at
E12.5 and ultimately results in a cleft secondary palate. Tp63-null mice
also exhibited loss of Barx1 expression, which has previously been
shown to result from perturbation of BMP/Fgf8 signaling (Barlow et
al,. 1999) and down-regulation of Shh, which is essential for the
survival and proliferation of facial mesenchyme cells (Hu and Helms,
1999; Ahlgren and Bronner-Fraser, 1999; Jeong et al., 2004) and has
important roles in both tooth germ and palate development (Zhang et
al., 2000, 2002). Taken together, our data uncover a crucial role for
Tp63 in the regulation of Bmp, Shh and Fgf8 signaling during facial
development. In this regard, it is interesting to note that a recent study
of Tp63-bound genes included those involved in cell adhesion,
proliferation and cell death and included members of the Notch,
Wnt and Tgfβ signaling pathways, including SMO, BMP1, BMP 7,
TGFβ1 and TGFβR3 (Yang et al., 2006). Exactly how Tp63 regulates the
expression of Bmp4, Fgf8 or Shh during facial development is currently
unknown. In this regard, however, chromatin immunoprecipitation
studies have indicated that Tp63 binds directly to Shh, whose
expression is induced in response to overexpression of Tp63 in vitro,
and is down-regulated in ﬁbroblasts extracted from Tp63−/− mice
(Caserta et al., 2006). In addition, previous reports suggested that Fgf8
transcripts were severely down-regulated/absent in Tp63mutant limb
buds (Yang et al., 1999, Mills et al., 1999), while other studies
demonstrated both Fgf8 and Shh expression in the Tp63 mutant
dental lamina (Laurikkala et al., 2006). To understand fully the role of
Tp63, it will be important to determine how Tp63 regulates its target
genes during facial, dental and limb development versus its role in
maintaining tissue-speciﬁc functions in the “stem cell niche” or in
preventing differentiation during epidermal development (Senoo
et al., 2007).
Recently, analysis of the mechanisms underlying cleft lip and
palate in knockout mice has helped to deﬁne the genetic pathways
governing fusion of the lip and palate. Simultaneously, analysis of DNA
samples from syndromic cases of cleft lip and palate has identiﬁed
previously uncharacterised genes, such as IRF6, in which mutations
cause orofacial clefting (Kondo et al., 2002). In addition, analysis of
DNA samples from non-syndromic cleft lip and palate patients has
indicated minor roles for mutations in MSX1, FOXE1, GLI2, MSX2, SKI,
and SPRY2 in the susceptibility for orofacial clefting (Riley et al., 2007).
Furthermore, polymorphisms in IRF6 have been found to be strongly
associated with non-syndromic cleft lip and palate and account for
approximately 12% of clefting (Zucchero et al., 2004). Identiﬁcation of
further Tp63 targets involved in controlling the balance between
apoptosis and proliferation during outgrowth of the facial processes
may reveal important information that furthers our knowledge of
facial morphogenesis and how this is perturbed in orofacial clefting.
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